Cardiac implantable electronic device placement following alcohol septal ablation for hypertrophic cardiomyopathy in the United States.

Journal of Cardiovascular Electrophysiology
Matthew C LamHerbert D Aronow

Abstract

Cardiac implantable electronic devices (CIED) are sometimes required after alcohol septal ablation (ASA) for hypertrophic cardiomyopathy (HCM). The primary objectives of this study were to characterize the incidence, timing, and predictors of CIED placement after ASA for HCM. Patients were identified from the 2010-2015 Nationwide Readmissions Databases. Incidence, timing and independent predictors of CIED placement, as well as 30-day readmission rates were examined. There were 1296 patients (national estimate = 2864) with HCM who underwent ASA. CIED were implanted in 322 (25% overall; 14% permanent pacemaker, 11% implantable cardioverter defibrillator) during the index hospitalization. Of these, 21%, 23%, 21%, and 18% occurred on postprocedure day 0, 1, 2, and 3, respectively. Only 17 (1.3%) patients underwent CIED implantation between discharge and 30-day follow up. Independent predictors of index hospitalization CIED implantation included older age, diabetes, heart failure, nonelective index hospital admission and hospitalization at a privately owned hospital. Nonelective 30-day readmission rates among those who did and did not undergo CIED placement during their index hospitalization, were 6.8% and 7.9%, respectively (p = .5...Continue Reading

References

Nov 16, 2004·Journal of the American College of Cardiology·Barry J MaronRick A Nishimura
Aug 2, 2005·Journal of the American College of Cardiology·Steve R OmmenRick A Nishimura
Aug 3, 2006·Journal of Interventional Cardiology·Mahboob AlamNasser Lakkis
Jul 27, 2007·JAMA : the Journal of the American Medical Association·Barry J MaronPaolo Bruzzi
Nov 19, 2011·Journal of the American College of Cardiology·Sherif F NaguehWilliam H Spencer
Apr 19, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Paul SorajjaSteve R Ommen
Sep 11, 2014·The American Journal of Cardiology·Sidakpal S PanaichTheodore Schreiber
Mar 31, 2015·Journal of the American College of Cardiology·Christopher SemsarianBarry J Maron
Aug 23, 2016·Journal of Interventional Cardiology·Ankit ChothaniApurva O Badheka
Sep 26, 2017·Annals of Cardiothoracic Surgery·Dustin HangHartzell V Schaff
Jan 24, 2018·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Nuno CardimUNKNOWN participating centres
Aug 12, 2018·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Patrick Fitzgerald, Fred Kusumoto
Oct 12, 2018·European Heart Journal. Quality of Care & Clinical Outcomes·Morten Kvistholm JensenJosef Veselka
Dec 14, 2018·Journal of the American College of Cardiology·Angelika BatznerHubert Seggewiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Cleveland Clinic Journal of Medicine
Cameron T Lambert, Khaldoun G Tarakji
Arrhythmia & Electrophysiology Review
Rikke Esberg KirkfeldtJens Cosedis Nielsen
Expert Review of Anti-infective Therapy
Muhammad Rizwan SohailSania S Raza
Cardiac Electrophysiology Clinics
Khalid AljabriChristopher Madias
© 2021 Meta ULC. All rights reserved